DK1981506T3 - Langtidsbehandling af HIV-infektion med TMC278 - Google Patents

Langtidsbehandling af HIV-infektion med TMC278

Info

Publication number: DK1981506T3
Authority: DK; Denmark
Prior art keywords: tmc278; long; hiv infection; term treatment; term
Prior art date: 2006-01-20

Application number

DK07712053.3T

Other languages

English (en)

Other versions

DK1981506T6 (da

Inventor

Lieven Elvire Colette Baert

Guenter Kraus

T Klooster Gerben Albert Eleutherius Van

Original Assignee

Janssen R & D Ireland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-01-20

Filing date

2007-01-19

Publication date

2013-06-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1981506(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-01-19 Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland

2013-06-24 Application granted granted Critical

2013-06-24 Publication of DK1981506T3 publication Critical patent/DK1981506T3/da

2021-06-14 Publication of DK1981506T6 publication Critical patent/DK1981506T6/da

Links

208000031886 HIV Infections Diseases 0.000 title 1
208000037357 HIV infectious disease Diseases 0.000 title 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title 1
238000011866 long-term treatment Methods 0.000 title 1
YIBOMRUWOWDFLG-ONEGZZNKSA-N rilpivirine Chemical compound CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC=2C=CC(=CC=2)C#N)=N1 YIBOMRUWOWDFLG-ONEGZZNKSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK07712053.3T 2006-01-20 2007-01-19 Langtidsbehandling af hiv-infektion med tcm278 DK1981506T6 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06100677		2006-01-20
PCT/EP2007/050516 WO2007082922A2 (en)	2006-01-20	2007-01-19	Long term treatment of hiv- infection with tcm278

Publications (2)

Publication Number	Publication Date
DK1981506T3 true DK1981506T3 (da)	2013-06-24
DK1981506T6 DK1981506T6 (da)	2021-06-14

Family

ID=36446113

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07712053.3T DK1981506T6 (da)	2006-01-20	2007-01-19	Langtidsbehandling af hiv-infektion med tcm278

Country Status (27)

Country	Link
US (4)	USRE50189E1 (da)
EP (1)	EP1981506B3 (da)
JP (2)	JP5754005B2 (da)
KR (2)	KR101501475B1 (da)
CN (2)	CN103877091A (da)
AP (1)	AP2936A (da)
AR (1)	AR059097A1 (da)
AU (1)	AU2007206901B2 (da)
BR (1)	BRPI0707179A2 (da)
CA (1)	CA2636436C (da)
CY (1)	CY1114089T1 (da)
DK (1)	DK1981506T6 (da)
EA (1)	EA014914B1 (da)
ES (1)	ES2414982T7 (da)
HR (1)	HRP20130544T4 (da)
IL (1)	IL192132A (da)
ME (1)	ME01617B (da)
MY (1)	MY150717A (da)
NZ (1)	NZ569347A (da)
PL (1)	PL1981506T6 (da)
PT (1)	PT1981506E (da)
RS (1)	RS52821B2 (da)
SG (1)	SG170073A1 (da)
SI (1)	SI1981506T1 (da)
TW (1)	TWI458483B (da)
UA (1)	UA96436C2 (da)
WO (1)	WO2007082922A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY169670A (en)	2003-09-03	2019-05-08	Tibotec Pharm Ltd	Combinations of a pyrimidine containing nnrti with rt inhibitors
TW201414495A (zh) *	2005-04-04	2014-04-16	Tibotec Pharm Ltd	Ｈｉｖ-感染之預防
UA96436C2 (ru)	2006-01-20	2011-11-10	Тиботек Фармасьютикелз Лтд.	Долгосрочное лечение вич-инфекции
AU2016219555B2 (en) *	2006-06-23	2017-08-10	Janssen Sciences Ireland Uc	Aqueous suspensions of TMC278
AU2014200819B2 (en) *	2006-06-23	2016-05-26	Janssen Sciences Ireland Uc	Aqueous suspensions of TMC278
EA021700B1 (ru) *	2006-06-23	2015-08-31	Тиботек Фармасьютикалз Лтд.	Фармацевтическая композиция, содержащая 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрил (тмс278) в форме суспензии микро- или наночастиц, способ ее получения и ее применение для длительного лечения или профилактики вич-инфекции
AR065720A1 (es)	2007-03-14	2009-06-24	Tibotec Pharm Ltd	Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
RU2546529C2 (ru) *	2008-12-24	2015-04-10	Тиботек Фармасьютикалз	Имплантируемые устройства для лечения вич
PL2480220T3 (pl) *	2009-09-22	2015-10-30	Janssen Sciences Ireland Uc	Leczenie i zapobieganie zakażeniu HIV
SG181759A1 (en)	2009-12-21	2012-07-30	Janssen R & D Ireland	Degradable removable implant for the sustained release of an active compound
LT2932970T (lt)	2010-01-27	2018-06-25	Viiv Healthcare Company	Antivirusinė terapija
TWI577377B (zh)	2010-09-16	2017-04-11	Ｖｉｉｖ醫療保健公司	醫藥組合物
US9266824B2 (en)	2014-01-13	2016-02-23	Warsaw Orthopedic, Inc.	Methods and compositions for making an amino acid triisocyanate
EP3377039B1 (en) *	2015-11-16	2024-01-03	Evonik Operations GmbH	Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
US20190163877A1 (en) *	2017-11-27	2019-05-30	International Business Machines Corporation	Decision support for effective long-term drug therapy
WO2022079739A1 (en)	2020-10-14	2022-04-21	Cipla Limited	Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
JPH06316524A (ja)	1992-09-11	1994-11-15	Naoyuki Inoue	抗エイズウイルス剤
US6045829A (en)	1997-02-13	2000-04-04	Elan Pharma International Limited	Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
UA72189C2 (uk)	1997-11-17	2005-02-15	Янссен Фармацевтика Н.В.	Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US6258932B1 (en)	1999-08-09	2001-07-10	Tripep Ab	Peptides that block viral infectivity and methods of use thereof
AU7984200A (en)	1999-09-21	2001-04-24	Skyepharma Canada Inc.	Surface modified particulate compositions of biologically active substances
EE200200564A (et)	2000-03-30	2004-06-15	Bristol-Myers Squibb Company	Stavudiini sisaldavad toimeainet aeglustatult vabastavad graanulid
US20040115268A1 (en)	2000-04-26	2004-06-17	Control Delivery Systems, Inc.	Systemic delivery of antiviral agents
MY169670A (en) *	2003-09-03	2019-05-08	Tibotec Pharm Ltd	Combinations of a pyrimidine containing nnrti with rt inhibitors
JO3429B1 (ar) *	2001-08-13	2019-10-20	Janssen Pharmaceutica Nv	مشتقات برميدينات مثبطة فيروس الايدز
US7638522B2 (en)	2001-08-13	2009-12-29	Janssen Pharmaceutica N.V.	Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
CA2465779A1 (en)	2001-11-20	2003-05-30	Advanced Inhalation Research, Inc.	Compositions for sustained action product delivery
US6568805B1 (en) *	2001-11-26	2003-05-27	Dan L. Dietz Trust	Magnetic buckle for eyeglasses
AU2003210659A1 (en) *	2002-01-24	2003-09-02	Sangstat Medical Corporation	Combination therapy for treatment of hiv infection
WO2004043433A2 (en)	2002-11-08	2004-05-27	Glaxo Group Limited	Pharmaceutical antiviral compositions
ES2477118T3 (es)	2002-11-18	2014-07-15	Polaris Group	Método para inhibir la replicaci�n viral in vivo
JP5602333B2 (ja)	2003-02-07	2014-10-08	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｈｉｖ感染の予防のためのピリミジン誘導体
EP1603546A1 (en)	2003-02-21	2005-12-14	Tripep AB	Glycinamide derivative for inhibiting hiv replication
ES2371442T7 (es) *	2004-09-02	2022-05-12	Janssen Pharmaceutica Nv	Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo
WO2006024668A1 (en) *	2004-09-02	2006-03-09	Janssen Pharmaceutica N.V.	Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile
KR20130030305A (ko)	2004-11-16	2013-03-26	엘란 파마 인터내셔널 리미티드	주사가능한 나노입자형 올란자핀 제형
TW201414495A (zh) *	2005-04-04	2014-04-16	Tibotec Pharm Ltd	Ｈｉｖ-感染之預防
UA96436C2 (ru)	2006-01-20	2011-11-10	Тиботек Фармасьютикелз Лтд.	Долгосрочное лечение вич-инфекции
EA021700B1 (ru)	2006-06-23	2015-08-31	Тиботек Фармасьютикалз Лтд.	Фармацевтическая композиция, содержащая 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрил (тмс278) в форме суспензии микро- или наночастиц, способ ее получения и ее применение для длительного лечения или профилактики вич-инфекции
WO2009007441A2 (en)	2007-07-12	2009-01-15	Tibotec Pharmaceuticals Ltd.	Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile

2007
- 2007-01-19 UA UAA200809750A patent/UA96436C2/ru unknown
- 2007-01-19 BR BRPI0707179-5A patent/BRPI0707179A2/pt not_active Application Discontinuation
- 2007-01-19 RS RS20130258A patent/RS52821B2/sr unknown
- 2007-01-19 CN CN201410126123.XA patent/CN103877091A/zh active Pending
- 2007-01-19 CA CA2636436A patent/CA2636436C/en active Active
- 2007-01-19 KR KR1020087018888A patent/KR101501475B1/ko active Active
- 2007-01-19 EA EA200870183A patent/EA014914B1/ru unknown
- 2007-01-19 PT PT77120533T patent/PT1981506E/pt unknown
- 2007-01-19 EP EP07712053.3A patent/EP1981506B3/en active Active
- 2007-01-19 TW TW096101983A patent/TWI458483B/zh active
- 2007-01-19 SG SG201101585-6A patent/SG170073A1/en unknown
- 2007-01-19 CN CNA2007800024269A patent/CN101370504A/zh active Pending
- 2007-01-19 NZ NZ569347A patent/NZ569347A/en unknown
- 2007-01-19 AU AU2007206901A patent/AU2007206901B2/en active Active
- 2007-01-19 ES ES07712053T patent/ES2414982T7/es active Active
- 2007-01-19 AR ARP070100247A patent/AR059097A1/es not_active Application Discontinuation
- 2007-01-19 JP JP2008550764A patent/JP5754005B2/ja active Active
- 2007-01-19 HR HRP20130544TT patent/HRP20130544T4/hr unknown
- 2007-01-19 US US17/473,424 patent/USRE50189E1/en active Active
- 2007-01-19 DK DK07712053.3T patent/DK1981506T6/da active
- 2007-01-19 US US12/161,445 patent/US10953009B2/en not_active Ceased
- 2007-01-19 KR KR1020147030400A patent/KR101562943B1/ko active Active
- 2007-01-19 SI SI200731253T patent/SI1981506T1/sl unknown
- 2007-01-19 ME MEP-2013-66A patent/ME01617B/me unknown
- 2007-01-19 PL PL07712053T patent/PL1981506T6/pl unknown
- 2007-01-19 AP AP2008004535A patent/AP2936A/xx active
- 2007-01-19 WO PCT/EP2007/050516 patent/WO2007082922A2/en not_active Ceased
- 2007-01-19 MY MYPI20082697 patent/MY150717A/en unknown
2008
- 2008-06-12 IL IL192132A patent/IL192132A/en active IP Right Grant
2013
- 2013-01-28 JP JP2013013118A patent/JP5836983B2/ja active Active
- 2013-06-27 CY CY20131100521T patent/CY1114089T1/el unknown
2021
- 2021-03-01 US US17/188,850 patent/US20210177843A1/en not_active Abandoned
2023
- 2023-08-22 US US18/236,734 patent/US20240226099A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW200806295A (en)	2008-02-01
EA014914B1 (ru)	2011-02-28
EP1981506B1 (en)	2013-03-27
JP5754005B2 (ja)	2015-07-22
KR101501475B1 (ko)	2015-03-19
TWI458483B (zh)	2014-11-01
DK1981506T6 (da)	2021-06-14
IL192132A (en)	2014-05-28
SG170073A1 (en)	2011-04-29
JP5836983B2 (ja)	2015-12-24
WO2007082922A2 (en)	2007-07-26
CN101370504A (zh)	2009-02-18
IL192132A0 (en)	2009-08-03
HK1125828A1 (en)	2009-08-21
HRP20130544T1 (en)	2013-07-31
JP2013100338A (ja)	2013-05-23
EP1981506B3 (en)	2021-06-09
NZ569347A (en)	2011-07-29
PL1981506T3 (pl)	2013-08-30
AR059097A1 (es)	2008-03-12
US10953009B2 (en)	2021-03-23
US20110275654A1 (en)	2011-11-10
WO2007082922A3 (en)	2007-09-20
AU2007206901B2 (en)	2013-01-31
PT1981506E (pt)	2013-06-25
KR101562943B1 (ko)	2015-10-23
ME01617B (me)	2014-09-20
EA200870183A1 (ru)	2009-12-30
US20240226099A1 (en)	2024-07-11
AU2007206901A1 (en)	2007-07-26
UA96436C2 (ru)	2011-11-10
MY150717A (en)	2014-02-28
US20210177843A1 (en)	2021-06-17
KR20080085194A (ko)	2008-09-23
RS52821B (sr)	2013-10-31
RS52821B2 (sr)	2021-07-30
BRPI0707179A2 (pt)	2011-04-26
WO2007082922A8 (en)	2008-01-03
CA2636436A1 (en)	2007-07-26
AP2936A (en)	2014-07-31
HRP20130544T4 (hr)	2021-08-20
USRE50189E1 (en)	2024-10-29
SI1981506T1 (sl)	2013-08-30
JP2009526758A (ja)	2009-07-23
PL1981506T6 (pl)	2021-07-12
CN103877091A (zh)	2014-06-25
AP2008004535A0 (en)	2008-08-31
CY1114089T1 (el)	2016-07-27
CA2636436C (en)	2014-04-01
KR20140141699A (ko)	2014-12-10
ES2414982T7 (es)	2021-11-05
ES2414982T3 (es)	2013-07-23
EP1981506A2 (en)	2008-10-22

Publication	Publication Date	Title
DK1981506T3 (da)	2013-06-24	Langtidsbehandling af HIV-infektion med TMC278
DK1976516T3 (da)	2013-07-15	Behandling af viral hepatitis
DK3494972T3 (da)	2024-01-29	Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion
DK2982696T3 (da)	2019-05-27	Behandling af akut lymfoblastær leukæmi
DK2125004T3 (da)	2020-06-15	Synergistisk terapeutisk anvendelse af prothrombinkompleks koncentrater med fviii koncentrater
DK2220076T3 (da)	2012-05-14	Inhibitorer af replikationen af humant immundefektvirus
DK2084174T3 (da)	2013-11-04	Fremstilling af ribofuranosylpyrimidinnukleotider
DK2122361T3 (da)	2014-06-23	Optisk bestemmelse af pH- og glucose-værdier
DK1986633T3 (da)	2014-11-03	Behandling af duchennes muskeldystrofi
DK2056807T3 (da)	2012-10-22	Behandling af inflammatoriske sygdomme
DK2019825T3 (da)	2010-11-22	Inhibitorer af human immundefektvirus-replikation
DK1981859T3 (da)	2013-01-21	Fremstilling af delmopinol
BRPI0820183A2 (pt)	2015-06-23	Prevenção e tratamento de infecções secundárias após infecção viral
DK2700786T3 (da)	2019-01-02	Modifikation af overførselspassage
DK2219647T3 (da)	2012-03-19	Terapeutiske anvendelser af forbindelser med kombineret sert-, 5-HT3- og 5-HT1A-aktivitet
DK2041270T3 (da)	2014-01-27	Fremstilling af glycoproteiner
DK2350416T4 (da)	2019-07-15	Multipel rude med mindst én antirefleksbehandling og anvendelse af antirefleksbehandling i multipel rude
DK2185191T3 (da)	2012-12-03	Influenzavacciner med lavt indhold af tilsætningsstoffer
DK3181682T3 (da)	2021-07-05	Reduceret kolonisering af mikrober på slimhinden
DK1945277T3 (da)	2013-05-27	Opretholdelse af desinfektion af medicinsk udstyr
DK2111555T3 (da)	2013-09-02	Diagnosticering af præeklampsi
DK2350116T3 (da)	2019-11-18	Behandling af biofilm
DK1732604T3 (da)	2010-11-15	Fremgangsmåder til behandling af hiv-infektion
DK2194784T3 (da)	2013-09-08	Kombinationer af aktive midler med insekticidale og acaricidale egenskaber
DK1776136T3 (da)	2012-12-03	Behandling af tilstande, der involverer demyelinisering